Maastricht University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Maastricht University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12363
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through its faculties and schools of arts and social sciences, business and economics, health, medicine and life sciences, humanities and sciences, law, and graduate school of governance, among others. The university also offers scientific research and education services in the STEM disciplines. MU is headquartered in Maastricht, the Netherlands.

Maastricht University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Maastricht University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Licensing Agreements 13
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
Equity Offering 15
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University – Key Competitors 16
Maastricht University – Key Employees 17
Maastricht University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Other Significant Developments 19
Aug 09, 2018: New study views cancer treatment as a game to find strategies that improve patient outcomes 19
Jan 19, 2017: CiMaas starts 2017 with successful first investment 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Maastricht University, Pharmaceuticals & Healthcare, Key Facts 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9
Maastricht University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Glucox Biotech Enters Into Collaboration with Maastricht University 11
Basic Pharma Enters into Co-Development Agreement with Maastricht University 12
Mirabilis Therapeutics Enters into Licensing Agreement with Maastricht University and Maastricht University Medical 13
Matisse Pharma Enters into Licensing Agreement with Maastricht University 14
CiMaas Spins Out from Maastricht University Medical Center 15
Maastricht University, Key Competitors 16
Maastricht University, Key Employees 17
Maastricht University, Subsidiaries 18

List of Figures
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Maastricht University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Maastricht University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Maastricht University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Maastricht University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Maastricht University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Maastricht University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiyoda Corporation:企業の戦略・SWOT・財務分析
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hamilton Thorne Ltd (HTL):医療機器:M&Aディール及び事業提携情報
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Polenergia SA (PEP):企業の財務・戦略的SWOT分析
    Polenergia SA (PEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Smurfit Kappa Group plc:企業のM&A・事業提携・投資動向
    Smurfit Kappa Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smurfit Kappa Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Airvolution Energy Limited:電力:M&Aディール及び事業提携情報
    Summary Airvolution Energy Limited (Airvolution) a subsidiary of Electricity Supply Board, is a renewable energy company that develops, construct and operate small onshore wind projects. It provides landowners a secure, long term revenue stream and takes all the financial risk during development of …
  • Tokuyama Corp (4043):電力:M&Aディール及び事業提携情報
    Summary Tokuyama Corp (Tokuyama), formerly Nihon Soda Kogyo Co., Ltd., manufactures and sells chemicals, specialty products and cement. Its product portfolio includes soda ash, caustic soda, silicon products, vinyl chloride monomer/polymer, fine chemicals, film products, medical materials, methylene …
  • Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatme …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Engie Brasil Energia SA (EGIE3):企業の財務・戦略的SWOT分析
    Engie Brasil Energia SA (EGIE3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • University of Alabama at Birmingham-製薬・医療分野:企業M&A・提携分析
    Summary University of Alabama at Birmingham (UAB), a subsidiary of University of Alabama System is an educational university that offers undergraduate and graduate programs. The university provides graduate programs in arts and sciences, health professions, medicine, nursing, business, dentistry, ed …
  • GC Pharma (006280):企業の財務・戦略的SWOT分析
    GC Pharma (006280) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kodiak Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kodiak Sciences Inc (Kodiak Sciences), formerly Oligasis LLC is a drug development company that discovers new medicines for the healthcare sector. The company provides retinal medicines for treatment of wet and dry forms of age-related macular degeneration. It utilizes proprietary Bioconjuga …
  • Power Grid Corporation of India Ltd (POWERGRID EQ):企業の財務・戦略的SWOT分析
    Power Grid Corporation of India Ltd (POWERGRID EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Sompo Japan Nipponkoa Holdings, Inc.:戦略・SWOT・企業財務分析
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Expro Holdings UK 2 Limited:企業の戦略的SWOT分析
    Expro Holdings UK 2 Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Advanced Biological Laboratories SA-医療機器分野:企業M&A・提携分析
    Summary Advanced Biological Laboratories SA (ABL) is a healthcare information technology company that provides integrated software solutions for personalised medicine. The company’s products include improving disease management software, project management software, cumulative reporting and related …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Estel Technologies Pvt. Ltd:企業の戦略的SWOT分析
    Estel Technologies Pvt. Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆